CervoMed Inc. (CRVO)

Latest Insider Confidence Score

2026Q1

57.0
Bullish

Company insider confidence (by quarter)

2008Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Stratus Media Group, Inc — 1,253,160,694 Jun 21, 2011
Blech Miriam — 43,750,000 Jun 1, 2011
Feller Paul — 26,238,427 Apr 15, 2010
Gilliam Richard Baxter — 12,687,975 Feb 19, 2016
Feller Ralph — 9,329,655 Mar 31, 2008

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 11, 2026 Feb 13, 2026 Winton Matthew Chief Commercial and Business Neutral 52.5 - 0.00% ✗ -
Feb 11, 2026 Feb 13, 2026 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
Feb 11, 2026 Feb 13, 2026 ELDER WILLIAM ROBERT CFO Neutral 52.5 - 0.00% ✗ -
Feb 11, 2026 Feb 13, 2026 De Rosch Mark EVP, RA and GA and PgM Neutral 52.5 - 0.00% ✗ -
Feb 11, 2026 Feb 13, 2026 Blackburn Kelly EVP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Feb 11, 2026 Feb 13, 2026 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Oct 27, 2025 Dec 5, 2025 Quigley David Director Neutral 52.5 - 0.00% ✗ -
Dec 5, 2025 Quigley David Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Winton Matthew Chief Commercial and Business Buy 91.3 +5,000 50.00% ✗ $41.4K
Nov 17, 2025 Nov 19, 2025 Gregoire Sylvie Director Buy 82.5 +21,600 1.46% ✗ $182.7K
Nov 17, 2025 Nov 19, 2025 ELDER WILLIAM ROBERT CFO Buy 91.3 +3,500 38.89% ✗ $29.3K
Nov 17, 2025 Nov 19, 2025 ALAM JOHN J CEO Buy 82.5 +21,600 1.46% ✗ $182.7K
Nov 13, 2025 Nov 17, 2025 Gregoire Sylvie Director Buy 72.5 +7,847 0.53% ✗ $59.1K
Nov 13, 2025 Nov 17, 2025 ALAM JOHN J CEO Buy 72.5 +7,847 0.53% ✗ $59.1K
Nov 14, 2025 Nov 17, 2025 Winton Matthew Chief Commercial and Business Buy 95.0 +10,000 100.00% ✗ $75.7K
Nov 12, 2025 Nov 13, 2025 Gregoire Sylvie Director Buy 61.3 +5,553 0.38% ✗ $40.8K
Nov 12, 2025 Nov 13, 2025 ELDER WILLIAM ROBERT CFO Buy 91.3 +3,500 63.64% ✗ $26K
Nov 12, 2025 Nov 13, 2025 ALAM JOHN J CEO Buy 61.3 +5,553 0.38% ✗ $40.8K
Oct 6, 2025 Oct 8, 2025 Winton Matthew Chief Commercial and Business Neutral 52.5 - 0.00% ✗ -
Oct 8, 2025 Winton Matthew Chief Commercial and Business Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 ZAVRL FRANK Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 BOGER JOSHUA S Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Sabbagh Marwan Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Poulton Jeffrey V. Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Hollingsworth Jane H Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
May 23, 2025 De Rosch Mark EVP, RA and GA and PgM Neutral 52.5 - 0.00% ✗ -
May 14, 2025 May 14, 2025 ELDER WILLIAM ROBERT CFO Buy 91.3 +4,233 334.10% ✗ $35.8K
Feb 4, 2025 Feb 14, 2025 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
Feb 4, 2025 Feb 14, 2025 ELDER WILLIAM ROBERT CFO Neutral 52.5 - 0.00% ✗ -
Feb 4, 2025 Feb 14, 2025 Cobuzzi Robert Joseph Jr. COO Neutral 52.5 - 0.00% ✗ -
Feb 4, 2025 Feb 14, 2025 Blackburn Kelly SVP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Feb 4, 2025 Feb 14, 2025 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Aug 27, 2024 Aug 27, 2024 ELDER WILLIAM ROBERT CFO Buy 91.3 +1,000 374.53% ✗ $18.2K
Jun 14, 2024 Jun 14, 2024 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 14, 2024 BOGER JOSHUA S Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 14, 2024 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 14, 2024 Hollingsworth Jane H Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 14, 2024 Poulton Jeffrey V. Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 14, 2024 Sabbagh Marwan Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 14, 2024 ZAVRL FRANK Director Neutral 52.5 - 0.00% ✗ -
Feb 26, 2024 Feb 28, 2024 BOGER JOSHUA S Director Neutral 52.5 -36 0.00% ✗ -
Feb 12, 2024 Feb 13, 2024 BOGER JOSHUA S Director Neutral 52.5 - 0.00% ✗ -
Feb 9, 2024 BOGER JOSHUA S Director Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 26, 2024 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 26, 2024 Blackburn Kelly SVP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 26, 2024 TANNER JOHN WILLIAM CFO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 26, 2024 ELDER WILLIAM ROBERT GC & Secretary Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 26, 2024 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 Jan 26, 2024 Cobuzzi Robert Joseph Jr. COO Neutral 52.5 - 0.00% ✗ -
Nov 20, 2023 Nov 22, 2023 TANNER JOHN WILLIAM CFO Neutral 52.5 - 0.00% ✗ -
Nov 9, 2023 Nov 9, 2023 Gregoire Sylvie Director Neutral 37.5 -10,000 -0.68% ✗ -
Nov 9, 2023 Nov 9, 2023 ALAM JOHN J CEO Neutral 37.5 -12,500 -0.85% ✗ -
Sep 15, 2023 Sep 15, 2023 Cobuzzi Robert Joseph Jr. COO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 TANNER JOHN WILLIAM CFO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 ZAVRL FRANK Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 Sabbagh Marwan Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 Poulton Jeffrey V. Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 Hollingsworth Jane H Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 ELDER WILLIAM ROBERT GC & Secretary Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 DAVIDSON JILL Director Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 15, 2023 Blackburn Kelly VP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Aug 31, 2023 Sep 6, 2023 Hollingsworth Jane H Director Neutral 27.5 -45 -4.77% ✗ -
Aug 25, 2023 ZAVRL FRANK Director Neutral 52.5 - 0.00% ✗ -
Aug 24, 2023 Sabbagh Marwan Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Blackburn Kelly VP, Clinical Development Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 ALAM JOHN J CEO Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Gregoire Sylvie Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Poulton Jeffrey V. Director Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 TANNER JOHN WILLIAM CFO Neutral 52.5 - 0.00% ✗ -
Aug 11, 2023 DAVIDSON JILL Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jul 5, 2023 LANCHONEY DIANA M Director Neutral 27.5 -85 -22.43% ✗ -
May 31, 2023 Jun 2, 2023 Hollingsworth Jane H Director Neutral 27.5 -68 -5.23% ✗ -
Mar 31, 2023 Apr 3, 2023 LANCHONEY DIANA M Director Neutral 27.5 -85 -36.64% ✗ -
Feb 28, 2023 Mar 3, 2023 Hollingsworth Jane H Director Neutral 27.5 -68 -5.74% ✗ -
Jan 31, 2023 Feb 3, 2023 Cobuzzi Robert Joseph Jr. CEO Neutral 27.5 -121 -6.97% ✗ -
Nov 30, 2022 Dec 2, 2022 Hollingsworth Jane H Director Neutral 27.5 -68 -6.36% ✗ -
Oct 31, 2022 Nov 2, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 27.5 -121 -7.90% ✗ -
Aug 31, 2022 Sep 2, 2022 Hollingsworth Jane H Director Neutral 27.5 -67 -7.03% ✗ -
Jun 7, 2022 Aug 26, 2022 JAEGER RAVEN Chief Regulatory Officer Neutral 52.5 - 0.00% ✗ -
Aug 26, 2022 JAEGER RAVEN Chief Regulatory Officer Neutral 52.5 - 0.00% ✗ -
Aug 1, 2022 Aug 3, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 27.5 -121 -9.13% ✗ -
May 31, 2022 Jun 2, 2022 Hollingsworth Jane H Director Neutral 27.5 -67 -8.00% ✗ -
May 2, 2022 May 3, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 27.5 -121 -10.81% ✗ -
Apr 18, 2022 Apr 19, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 52.5 - 0.00% ✗ -
Apr 18, 2022 Apr 19, 2022 ELDER WILLIAM ROBERT GC & Secretary Neutral 52.5 - 0.00% ✗ -
Mar 18, 2022 Mar 22, 2022 ELDER WILLIAM ROBERT GC & Secretary Neutral 52.5 - 0.00% ✗ -
Mar 18, 2022 Mar 22, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 52.5 - 0.00% ✗ -
Nov 1, 2021 Feb 2, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 27.5 -6,049 -19.93% ✗ -
Jan 31, 2022 Feb 2, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 27.5 -6,049 -14.88% ✗ -
Jan 27, 2022 Jan 31, 2022 Hornung William Karl CFO Neutral 52.5 - 0.00% ✗ -
Jan 27, 2022 Jan 31, 2022 GALLOWAY CHRISTOPHER D Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 27, 2022 Jan 31, 2022 ELDER WILLIAM ROBERT GC & Secretary Neutral 52.5 - 0.00% ✗ -
Jan 27, 2022 Jan 31, 2022 Cobuzzi Robert Joseph Jr. CEO Neutral 52.5 - 0.00% ✗ -
Nov 1, 2021 Nov 3, 2021 Cobuzzi Robert Joseph Jr. CEO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Oct 15, 2021 LANCHONEY DIANA M Director Neutral 52.5 - 0.00% ✗ -
Oct 15, 2021 LANCHONEY DIANA M Director Neutral 52.5 - 0.00% ✗ -